Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Positive outcome for phase II study of Periostat as adjunctive treatment for rosacea

July 3, 2003

Phase II findings for onercept in psoriasis and psoriatic arthritis

June 30, 2003

Enbrel improves plaque psoriasis symptoms in phase III study

June 27, 2003

VIC-acne completes phase I safety study

June 25, 2003

Shiseido synthesizes new MMP inhibitors

June 23, 2003

Dompe patents novel inhibitors of IL-8 and GROalpha-induced chemotaxis

June 18, 2003

Interim results for rAAT in otitis media

June 17, 2003

Fibrostat phase IIb trial cleared to commence

June 16, 2003

Nonhypercalcemic vitamin D analogues newly synthesized at Schering AG

June 16, 2003

Reepithelialization of second degree burns enhanced in pigs administered CNI-1493

June 16, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...